Web Results


... et al v. GR Supply Chain Management Inc et al ... 1/19/2017 · 1:17-cv-00386 · Penguin Random House LLC et al v. Frederick ... Finch v. L'Oreal USA, Inc. et al ...


Parties, docket activity and news coverage of federal case McCoy v. Nestle USA, Inc et al, case number 3:15-cv-04451, from California Northern Court.


Jan 14, 2016 ... 50.6 %, p < 0.01) and the “FET with a previous fresh ET” (59.5 vs. ... IL), an antagonist protocol (Ganirelix Acetate®, Organon USA Inc., Roseland, ... The Cryotop method for embryo vitrification was that described by Kuwayama et al. ...... Garrido-Gómez T1, Ruiz-Alonso M, Blesa D, Diaz-Gimeno P, Vilella F, ...


Aug 30, 2008 ... Recombinant FSH (Follistim®, Organon USA Inc, Roseland, NJ, USA) ... Gomez- Palomares et al. reported a pregnancy rate of 38% versus 14% ...


Apr 27, 2016 ... 3:13-CV-02110 Orchestrate HR Inc. v. ... 3:13-CV-04323 St. Martin v. USA. 3:14- CV-01096 Doe I, et al. v. ... 3:14-CV-02934 Gomez, et al. v.


DC Anderson, B Gomez-Mancilla, BB Spear, DM Barnes, K Cheeseman, PM Shaw, ... West Point, PA, USA; 11Wyeth Research, Wyeth Pharmaceuticals, Inc., ..... for result sharing vs the need for and benefit of disclosure of information to the subject. ..... for human genetic samples (reviewed by Knoppers et al co-workers).


Jun 11, 2012 ... Denise Molina-Gomes, .... 6.6±3.1 UI/l (p=0.0126) for FSH and 4.8±2.3 IU/l vs. ..... Our results agree with previous data in this respect (Hanevik et al. .... FSH ( GonalF® from Merck Serono or Puregon® from Organon-Schering Plough) ... procedure (SAS Institute Inc., Cary, NC, USA), with the hypothesis of a ...


Celso E Gomez-Sanchez2 and William E Rainey. Department of ... 1Hollis-Eden Pharmaceuticals, Inc., San Diego, California 921222, USA ... DHEA production in the adrenal cells (Hornsby et al. 1973, ... vehicle or 10 nM ACTH (Organon, Bedford, OH, USA) for .... (42 vs 30%), while androstenedione was also produced in.


Jul 12, 2014 ... Wu et al.; licensee BioMed Central Ltd. 2014 ... recovery with sugammadex vs neostigmine in Chinese subjects. ... has been established by the TOF-Watch® SX (Organon Ireland Ltd., a subsidiary of Merck and Co., Swords, Co. ..... Inc., Whitehouse Station, NJ, USA. provided financial support to the study.